KMT2D and urinary bladder cancer: We defined 30 frequently mutated genes in American bladder cancer samples from TCGA cohort, and the five most frequently mutated genes were TP53 (47%), TTN (40%), KMT2D (26%), KDM6A (25%), and ARID1A (24%) (Figure 1A).